References
- An D, Yao ZY, He GY. (1996). With fluoride medium - pepper in fluorine pollution status in Guizhou. Endem Dis Bull 11: 55–57.
- Babbar S, Chanda S, Bley K. (2010). Inhibition and induction of human cytochrome P450 enzymes in vitro by capsaicin. Xenobiotica 40:807–816.
- Belza A, Frandsen E, Kondrup J. (2007). Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects. Int J Obes (Lond) 31:121–130.
- Bode AM, Dong Z. (2011). The two faces of capsaicin. Cancer Res 71:2809–2814.
- Chen XW, Serag ES, Sneed KB, Zhou SF. (2011). Herbal bioactivation, molecular targets and the toxicity relevance. Chem Biol Interact 192:161–176.
- Díaz-Laviada I. (2010). Effect of capsaicin on prostate cancer cells. Future Oncol 6:1545–1550.
- Gooding SM, Canter PH, Coelho HF, Boddy K, Ernst E. (2010). Systematic review of topical capsaicin in the treatment of pruritus. Int J Dermatol 49:858–865.
- Hachiya S, Kawabata F, Ohnuki K, Inoue N, Yoneda H, Yazawa S, Fushiki T. (2007). Effects of CH-19 Sweet, a non-pungent cultivar of red pepper, on sympathetic nervous activity, body temperature, heart rate, and blood pressure in humans. Biosci Biotechnol Biochem 71:671–676.
- Hayman M, Kam PCA. (2008). Capsaicin: a review of its pharmacology and clinical applications. Curr Anaesth Crit Care 19:338–343.
- Hirotani Y, Yamamoto K, Tomishi H, Nishihori T, Umeda T, Tanaka K. (2007). Effects of capsaicin on the pharmacokinetics of digoxin, phenytoin, and theophylline in rats. Jpn J TDM 24:23–28.
- Isik AT, Bozoglu E, Naharci MI, Kilic S. (2010). Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer’s disease. Am J Geriatr Pharmacother 8:454–459.
- Josse AR, Sherriffs SS, Holwerda AM, Andrews R, Staples AW, Phillips SM. (2010). Effects of capsinoid ingestion on energy expenditure and lipid oxidation at rest and during exercise. Nutr Metab (Lond) 7:65.
- Kanazu T, Sato N, Kadono K, Touchi A, Takeda Y, Yamaguchi Y, Baba T. (2012). Investigation of drug-drug interaction via mechanism-based inhibition of cytochrome P450 3A by macrolides in dexamethasone-treated female rats. Biopharm Drug Dispos 33:195–206.
- Lim K, Yoshioka M, Kikuzato S, Kiyonaga A, Tanaka H, Shindo M, Suzuki M. (1997). Dietary red pepper ingestion increases carbohydrate oxidation at rest and during exercise in runners. Med Sci Sports Exerc 29:355–361.
- Maláková J, Nobilis M, Svoboda Z, Lísa M, Holcapek M, Kvetina J, Klimes J, Palicka V. (2007). High-performance liquid chromatographic method with UV photodiode-array, fluorescence and mass spectrometric detection for simultaneous determination of galantamine and its phase I metabolites in biological samples.. J Chromatogr B Analyt Technol Biomed Life Sci 853:265–274.
- Mark H, Peter CAK. (2008). Capsaicin: a review of its pharmacology and clinical applications. Curr Anesth Crit Care 19:338–343.
- Pawlowska M, Augustin E. (2011). [Expression systems of cytochrome P450 proteins in studies of drug metabolism in vitro]. Postepy Hig Med Dosw (Online) 65:367–376.
- Perucka I, Oleszek W. (2000). Extraction and determination of capsaicinoids in fruit of hot pepper Capsicum annuum L. by spectrophotometry and high-performance liquid chromatography. Food Chem 71:287–291.
- Reyes-Escogido Mde L, Gonzalez-Mondragon EG, Vazquez-Tzompantzi E. (2011). Chemical and pharmacological aspects of capsaicin. Molecules 16:1253–1270.
- Takanohashi T, Isaka M, Ubukata K, Mihara R, Bernard BK. (2010). Studies of the toxicological potential of capsinoids, XIII: inhibitory effects of capsaicin and capsinoids on cytochrome P450 3A4 in human liver microsomes. Int J Toxicol 29:22S–26S.
- Yuan R, Madani S, Wei XX, Reynolds K, Huang SM. (2002). Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions. Drug Metab Dispos 30:1311–1319.
- Zhou S, Koh HL, Gao Y, Gong ZY, Lee EJ. (2004). Herbal bioactivation: the good, the bad and the ugly. Life Sci 74:935–968.
- Zhou SF, Xue CC, Yu XQ, Wang G. (2007). Metabolic activation of herbal and dietary constituents and its clinical and toxicological implications: an update. Curr Drug Metab 8:526–553.